As a premier Pharmaceutical Products Supplier for the Uzbekistan market, Jiangxi Serum Pharma understands the unique dynamics of the "New Uzbekistan" strategy. With a population exceeding 36 million and a government aggressively modernizing its healthcare infrastructure, Uzbekistan has emerged as the most significant pharmaceutical hub in Central Asia. Currently, the market relies on imports for approximately 75% of its pharmaceutical needs, creating a vital bridge for Chinese manufacturers offering GMP-certified excellence.
The Tashkent and Samarkand regions are witnessing a surge in "Pharmaceutical Clusters," backed by presidential decrees aimed at ensuring drug safety and affordability. The regulatory environment, governed by the Agency for the Development of the Pharmaceutical Industry, is aligning with international standards, necessitating suppliers who possess not just products, but deep technical dossiers and clinical validation. Our role as a supplier extends beyond logistics; we provide the "Information Gain" necessary for local distributors to navigate registration and compliance.
In the post-pandemic era, "Supply Chain Resilience" is the primary intent for Uzbekistan's B2B procurement officers. Our integrated Factory 4.0 approach utilizes IoT-enabled manufacturing and real-time logistics tracking to ensure that pharmaceutical intermediates and finished dosages reach Tashkent without delay.
End-to-end visibility from fermentation tanks in China to the customs warehouse in Uzbekistan.
Rigorous quality control ensuring every batch meets the high purity standards of international pharmacopeias.
Addressing the growing demand for specialized animal nutrition in Uzbekistan's expanding poultry sector.
Advanced molecular engineering to enhance the bioavailability of APIs in challenging climates.
Sustainable production of antibiotics and enzymes using state-of-the-art biological processes.
Plant-derived ingredients for the booming Uzbek dermo-cosmetic and supplement industry.
In Tashkent’s state-of-the-art clinics, our Enrofloxacin and Dexamethasone solutions provide rapid-response treatment for critical infections, ensuring patient safety through high-purity western medicine standards.
Uzbekistan's livestock sector in the Fergana Valley utilizes our Ivermectin and Albendazole suspensions to maintain herd health, directly contributing to national food security and export potential.
We provide high-quality raw materials and intermediates to local Uzbek pharmaceutical startups, fostering a culture of innovation and local manufacturing self-sufficiency.
A: Uzbekistan requires a CTD format dossier. Jiangxi Serum Pharma provides full documentation support, including GMP certificates and COA (Certificate of Analysis) to expedite the registration process with the Uzbek health authorities.
A: We utilize specialized thermo-controlled packaging and partner with reliable logistics providers that offer continuous temperature monitoring from our facility to Tashkent International Airport.
A: Yes, we offer Pre-mix and custom concentration services (like our 30%/50% Amoxicillin) tailored to the specific pathogenic challenges found in Central Asian livestock.
The global shift toward sustainable squalene is impacting the Central Asian cosmetic raw material supply...
Read More →Why this API remains a cornerstone for modern emergency medicine in developing healthcare markets...
Read More →FDA approval of oral GLP1 molecules signals a new era for metabolic health solutions worldwide...
Read More →Partner with Jiangxi Serum Pharma – Your reliable Pharmaceutical Products Supplier for the Uzbekistan market. Quality, Compliance, and Growth delivered.
Start Your Order Today
